23andMe Revenue and Competitors
Estimated Revenue & Valuation
- 23andMe's estimated annual revenue is currently $258.5M per year.
- 23andMe received $300.0M in venture funding in July 2018.
- 23andMe's estimated revenue per employee is $287,862
- 23andMe's total funding is $1.1B.
- 23andMe's current valuation is $2.4B. (January 2022)
Employee Data
- 23andMe has 898 Employees.
- 23andMe grew their employee count by -10% last year.
23andMe's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Head Therapeutic Discovery | Reveal Email/Phone |
3 | VP Portfolio Strategy and Alliance Management | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | VP, Genetic Technology | Reveal Email/Phone |
6 | VP, Research | Reveal Email/Phone |
7 | VP & Chief Architect | Reveal Email/Phone |
8 | VP, Investor Relations | Reveal Email/Phone |
9 | VP, UK & Europe (ex CEO Lemonaid) | Reveal Email/Phone |
10 | Executive Assistant to Chief Corporate Development Officer | Reveal Email/Phone |
23andMe Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $98.6M | 544 | 1% | N/A | N/A |
#2 | $387.8M | 1937 | 6% | $33.2M | N/A |
#3 | $434.8M | 1865 | -14% | $2B | $2.7B |
What Is 23andMe?
23andMe, Inc. is the leading consumer genetics and research company. Our mission is to help people access, understand and benefit from the human genome. The company was named by MIT Technology Review to its 50 Smartest Companies, 2017 list, and named one of Fast Company's 25 Brands That Matter Now, 2017. 23andMe has over 5 million customers worldwide, with ~80 percent of customers consented to participate in research. 23andMe, Inc. is located in Mountain View, CA. More information is available at www.23andMe.com.
keywords:Direct Sales,Biotechnology,Healthcare,Human Resources Hr,Medical Diagnostics,Search
$1.1B
Total Funding
898
Number of Employees
$258.5M
Revenue (est)
-10%
Employee Growth %
$2.4B
Valuation
N/A
Accelerator
23andMe News
It was from 23andMe and the subject line read simply: You have new DNA relatives." I wasn't particularly surprised.
Evolving Opportunities with 23andMe Inc. & Abbott Laboratories |Technavio...
We have people on death row that are taking 23andMe DNA tests trying to get their convictions overturned, Stitt said Wednesday night on...
What You Should Know: – Consumer genetics and research company 23andMe, today announced a definitive merger agreement with Lemonaid Health, Inc., an on-demand platform for accessing medical care and pharmacy services online. – As part of the merger agreement, 23andMe acquired Lemonaid Health f ...
An Unknown Risk That's what happened for Wayne, and he's spent the last several years trying to help others to do the same. He recently sat down with us at 23andMe to talk about his journey from an average American guy to a man who started a foundation to save others like him and help them on ...
Other Companies in Mountain View
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $179.8M | 898 | -14% | $415M |
#2 | $75M | 904 | 7% | N/A |
#3 | $206.5M | 922 | 109% | N/A |
#4 | $175.9M | 946 | 1% | $644.5M |
#5 | N/A | 1011 | 1% | N/A |
23andMe Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2007-10-04 | $9.0M | A | Article | |
| 2009-05-05 | $11.0M | Second | Article | |
| 2009-06-19 | $2.6M | Undisclosed | Article | |
| 2009-12-24 | $14.2M | B | Article | |
| 2010-11-10 | $22.0M | Third | Johnson/Johnson Development Co | Article |
| 2011-01-18 | $9.0M | Undisclosed | MPM Capital, Johnson & Johnson Development | Article |
| 2015-07-08 | $79.0M | Undisclosed | Article | |
| 2015-10-15 | $115.0M | E | Fidelity Management and Research Company | Article |
| 2017-09-13 | $250.0M | Undisclosed | Sequoia Capital | Article |
| 2018-07-27 | $300.0M | Undisclosed | Article |